Katharine E Harding1, Mark Wardle2, Robert Carruthers2, Neil Robertson2, Feng Zhu2, Elaine Kingwell2, Helen Tremlett2. 1. From the Faculty of Medicine (Neurology) and Djavad Mowafaghian Centre for Brain Health (K.E.H., R.C., F.Z., E.K., H.T.), University of British Columbia, Vancouver, Canada; Institute of Psychological Medicine and Clinical Neuroscience (K.E.H., N.R.), Cardiff University, University Hospital of Cardiff; and Helen Durham Centre for Neuroinflammatory Disease, Department of Neurology (M.W., N.R.), University Hospital of Wales, Heath Park, Cardiff, UK. katharineharding@doctors.org.uk. 2. From the Faculty of Medicine (Neurology) and Djavad Mowafaghian Centre for Brain Health (K.E.H., R.C., F.Z., E.K., H.T.), University of British Columbia, Vancouver, Canada; Institute of Psychological Medicine and Clinical Neuroscience (K.E.H., N.R.), Cardiff University, University Hospital of Cardiff; and Helen Durham Centre for Neuroinflammatory Disease, Department of Neurology (M.W., N.R.), University Hospital of Wales, Heath Park, Cardiff, UK.
Abstract
OBJECTIVE: To examine the association between socioeconomic status (SES) and disability outcomes and progression in multiple sclerosis (MS). METHODS: Health administrative and MS clinical data were linked for 2 cohorts of patients with MS in British Columbia (Canada) and South East Wales (UK). SES was measured at MS symptom onset (±3 years) based on neighborhood-level average income. The association between SES at MS onset and sustained and confirmed Expanded Disability Status Scale (EDSS) 6.0 and 4.0 and onset of secondary progression of MS (SPMS) were assessed using Cox proportional hazards models. EDSS scores were also examined via linear regression, using generalized estimating equations (GEE) with an exchangeable working correlation. Models were adjusted for onset age, sex, initial disease course, and disease-modifying drug exposure. Random effect models (meta-analysis) were used to combine results from the 2 cohorts. RESULTS: A total of 3,113 patients with MS were included (2,069 from Canada; 1,044 from Wales). A higher SES was associated with a lower hazard of reaching EDSS 6.0 (adjusted hazard ratio [aHR] 0.90, 95% confidence interval [CI] 0.89-0.91), EDSS 4.0 (aHR 0.93, 0.88-0.98), and SPMS (aHR 0.94, 0.88-0.99). The direction of findings was similar when all EDSS scores were included (GEE: β = -0.13, -0.18 to -0.08). CONCLUSIONS: Lower neighborhood-level SES was associated with a higher risk of disability progression. Reasons for this association are likely to be complex but could include factors amenable to modification, such as lifestyle or comorbidity. Our findings are relevant for planning and development of MS services.
OBJECTIVE: To examine the association between socioeconomic status (SES) and disability outcomes and progression in multiple sclerosis (MS). METHODS: Health administrative and MS clinical data were linked for 2 cohorts of patients with MS in British Columbia (Canada) and South East Wales (UK). SES was measured at MS symptom onset (±3 years) based on neighborhood-level average income. The association between SES at MS onset and sustained and confirmed Expanded Disability Status Scale (EDSS) 6.0 and 4.0 and onset of secondary progression of MS (SPMS) were assessed using Cox proportional hazards models. EDSS scores were also examined via linear regression, using generalized estimating equations (GEE) with an exchangeable working correlation. Models were adjusted for onset age, sex, initial disease course, and disease-modifying drug exposure. Random effect models (meta-analysis) were used to combine results from the 2 cohorts. RESULTS: A total of 3,113 patients with MS were included (2,069 from Canada; 1,044 from Wales). A higher SES was associated with a lower hazard of reaching EDSS 6.0 (adjusted hazard ratio [aHR] 0.90, 95% confidence interval [CI] 0.89-0.91), EDSS 4.0 (aHR 0.93, 0.88-0.98), and SPMS (aHR 0.94, 0.88-0.99). The direction of findings was similar when all EDSS scores were included (GEE: β = -0.13, -0.18 to -0.08). CONCLUSIONS: Lower neighborhood-level SES was associated with a higher risk of disability progression. Reasons for this association are likely to be complex but could include factors amenable to modification, such as lifestyle or comorbidity. Our findings are relevant for planning and development of MS services.
Authors: Eleni S Vasileiou; Angeliki G Filippatou; Daniela Pimentel Maldonado; Grigorios Kalaitzidis; Henrik Ehrhardt; Jeffrey Lambe; Shiv Saidha; Elias S Sotirchos; Ellen M Mowry; Peter A Calabresi; Kathryn C Fitzgerald Journal: Brain Date: 2021-12-31 Impact factor: 13.501
Authors: Devi Sai Sri Kavya Boorgu; Shruthi Venkatesh; Chirag M Lakhani; Elizabeth Walker; Ines M Aguerre; Claire Riley; Chirag J Patel; Philip L De Jager; Zongqi Xia Journal: Mult Scler Relat Disord Date: 2022-06-24 Impact factor: 4.808
Authors: Yujie Wang; Fan Tian; Kathryn C Fitzgerald; Jagriti Jackie Bhattarai; Robert T Naismith; Megan Hyland; Peter A Calabresi; Ellen M Mowry Journal: Mult Scler Relat Disord Date: 2020-02-14 Impact factor: 4.339
Authors: Jeffrey Lambe; Kathryn C Fitzgerald; Olwen C Murphy; Angeliki G Filippatou; Elias S Sotirchos; Grigorios Kalaitzidis; Elena Vasileiou; Nicole Pellegrini; Esther Ogbuokiri; Brandon Toliver; Nicholas J Luciano; Simidele Davis; Nicholas Fioravante; Ohemaa Kwakyi; Hunter Risher; Ciprian M Crainiceanu; Jerry L Prince; Scott D Newsome; Ellen M Mowry; Shiv Saidha; Peter A Calabresi Journal: Neurology Date: 2021-03-02 Impact factor: 9.910
Authors: Daniela A Pimentel Maldonado; Justin R Eusebio; Lilyana Amezcua; Eleni S Vasileiou; Ellen M Mowry; Christopher C Hemond; Raffaella Umeton Pizzolato; Idanis Berrios Morales; Irina Radu; Carolina Ionete; Kathryn C Fitzgerald Journal: Mult Scler Relat Disord Date: 2021-12-05 Impact factor: 4.808